Hepatitis News : BMS Officially Halts Development of NS5B Inhibitor for Hep C

A Smart + Strong Site
Subscribe to:
Hepatitis E-newsletter
Join Us:

Back to home » Hepatitis News » August 2012


emailprint

August 27, 2012

BMS Officially Halts Development of NS5B Inhibitor for Hep C

Bristol-Myers Squibb (BMS) has officially halted development of BMS-986094, a once-promising nucleotide polymerase (NS5B) inhibitor, according to a statement from the company released Thursday, August 23. The decision follows the termination of a Phase II clinical trial of the drug, in which one volunteer experienced heart failure and died and eight other patients were hospitalized for heart- and kidney-related problems. “In the interest of all patients participating in hepatitis C clinical studies, and in cooperation with the FDA, we will make relevant information on BMS-986094 available to inform the development of other investigational compounds to treat hepatitis C. We will also work expeditiously to share the results of our further investigations more broadly in the medical and scientific community,” said Elliott Sigal, MD, PhD, executive vice president and chief scientific officer at BMS.

To read the BMS statement, click here.
To read the Phase II clinical trial termination report, click here.

Search: hepatitis, hcv, bms-986094, polymerase, ns5b, nucleotide, discontinuation, heart, kidney, death, bristol-myers squibb, bms


Scroll down to comment on this story. Click here to visit the Hep Forums and ask questions about this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The Hep team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)


[Go to top]

Quick Links
Current Issue
Forums
Poll
Blogs
Hep TV
Calendar
Services Directory
Conference News
Top Stories
Treatment News
Hep Exclusives
All About Hepatitis
• Hepatitis A
Transmission
Prevention
Treatment
• Hepatitis B
Transmission
Prevention
Treatment
• Hepatitis C
Transmission
Prevention
Treatment
HCV/HIV Coinfection
Help Paying For Meds
Clinical Trials
TALK TO US
Tell us what you think
Poll
Would you consider using medical marijuana to help ease side-effects of hepatitis C treatment?
Yes
No
Not sure


Survey
USA Today/Hepatitis C Awareness Survey

Hepatitis C Reader Survey
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.